Enveric Biosciences Files Q1 2025 10-Q

Ticker: ENVB · Form: 10-Q · Filed: May 14, 2025 · CIK: 890821

Enveric Biosciences, Inc. 10-Q Filing Summary
FieldDetail
CompanyEnveric Biosciences, Inc. (ENVB)
Form Type10-Q
Filed DateMay 14, 2025
Risk Levelmedium
Sentimentneutral

Sentiment: neutral

Topics: 10-Q, pharmaceuticals, financial-reporting

TL;DR

Enveric Biosciences filed their Q1 2025 10-Q. All good.

AI Summary

Enveric Biosciences, Inc. filed its quarterly report for the period ending March 31, 2025. The company, previously known as AMERI Holdings, Inc. and SPATIALIZER AUDIO LABORATORIES INC, is in the pharmaceutical preparations industry. Their business address is located in Naples, Florida.

Why It Matters

This filing provides an update on Enveric Biosciences' financial status and operations for the first quarter of 2025, which is crucial for investors to assess the company's performance and outlook.

Risk Assessment

Risk Level: medium — As a pharmaceutical company, Enveric Biosciences faces inherent risks related to drug development, regulatory approvals, and market competition.

Key Numbers

  • 20250331 — Reporting Period End Date (Indicates the end of the fiscal quarter being reported.)
  • 20250514 — Filing Date (The date the 10-Q was officially submitted to the SEC.)

Key Players & Entities

  • Enveric Biosciences, Inc. (company) — Filer of the 10-Q
  • 20250331 (date) — End of the reporting period
  • AMERI Holdings, Inc. (company) — Former company name
  • SPATIALIZER AUDIO LABORATORIES INC (company) — Former company name
  • Naples, Florida (location) — Business address location

FAQ

What is the primary business of Enveric Biosciences, Inc.?

Enveric Biosciences, Inc. is in the Pharmaceutical Preparations industry, with the Standard Industrial Classification code [2834].

When did Enveric Biosciences, Inc. change its name from AMERI Holdings, Inc.?

The date of the name change from AMERI Holdings, Inc. was 20150527.

What is the business address of Enveric Biosciences, Inc.?

The business address is 4851 Tamiami Trail N, Suite 200, Naples, Florida, 34103.

What is the SEC file number for Enveric Biosciences, Inc.?

The SEC file number is 001-38286.

What fiscal period does this 10-Q filing cover?

This 10-Q filing covers the period ending March 31, 2025 (Q1 2025).

Filing Details

This Form 10-Q (Form 10-Q) was filed with the SEC on May 14, 2025 regarding Enveric Biosciences, Inc. (ENVB).

View full filing on EDGAR

View Full Filing

View this 10-Q filing on SEC EDGAR

View on ReadTheFiling | About | Contact | Privacy | Terms

Data from SEC EDGAR. Not affiliated with the SEC. Not investment advice. © 2026 OpenDataHQ.